To determine the effects of dual inhibition of SKP2 and Aur-A, we first identified the IC50 of Aur-A kinase inhibitor MLN8237 and SKP2 inhibitor SZL P1-41 in different ccRCC cell lines. This evidence concerns the gene AURKA and nonpapillary renal cell carcinoma.